Related ArticlesDefining co-related parameters between ‘metabolic’ flare and ‘clinical’, ‘biochemical’, and ‘osteoblastic’ flare and establishing guidelines for assessing response to treatment in cancer.

Eur J Nucl Med Mol Imaging. 2006 Oct 27;

Authors: Basu S, Alavi A

PMID: 17072613 [PubMed - as supplied by publisher]

]]>

[Feasibility test of a new guideline--results of qualitative research with general practitioners]

Z Arztl Fortbild Qualitatssich. 2006;100(6):461-5

Authors: Brockmann S, Maisel P

Feasibility testing of new guidelines for general practice is part of the German Academic Society of General Practice’s evaluation procedure. The ‘low back pain guideline’ was evaluated by a qualitative method that included a focus group discussion. Even when GPs agreed to guideline recommendations, this method revealed emotional and cultural barriers to implementation on the part of both doctors and patients.

PMID: 17058891 [PubMed - in process]

]]>

World association for the advancement of veterinary parasitology (WAAVP): second edition of guidelines for evaluating the efficacy of anthelmintics in swine.

Vet Parasitol. 2006 Oct 10;141(1-2):138-49

Authors: Hennessy DR, Bauer C, Boray JC, Conder GA, Daugschies A, Johansen MV, Maddox-Hyttel C, Roepstorff A,

Guidelines are provided for evaluating the efficacy of anthelmintics in swine which, in conjunction with other sets of guidance such as those of the International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products (VICH GL7 and VICH GL16), should encourage the adoption of uniform registration requirements globally. Testing of efficacy should be carried out according to the principles of “Good Clinical Practice” (VICH GL9, 2000). Data obtained according to these guidelines should be internationally acceptable for the registration of anthelmintics for swine. Further, the use of the guidelines should expedite development, government review, and approval of anthelmintics for swine, as well as contribute towards reducing costs and the number of experimental animals used for drug testing.

PMID: 16806712 [PubMed - in process]

]]>